Georgia BioEd Completes Inaugural Rural Teacher Training Initiative

The Georgia BioEd Institute, together with Georgia Youth Science and Technology Centers and the Georgia Department of Education, hosted the inaugural Rural Teacher Training Initiative (RTTI) at UGA’s Griffin Campus on January 13 th and 14 th , 2020.

Seventy-two science teachers in 7th through 12th grade representing 40 Georgia school districts participated. More than 10,000 students in rural Georgia communities stand to benefit. The curriculum for the two-day symposium is based on Georgia life science industry needs and is aligned with Georgia Standards of Excellence as well as the Technical College System of Georgia’s biotechnology programs. Educators practiced new, hands-on, biotech laboratory activities to take back to their classrooms. They connected with industry leaders and recruiters while also collecting contributed laboratory equipment from our industry partners.

Georgia BioEd Rural Teacher Training Initiative (RTTI) participants

The GaBioEd Institute will deliver the balance of all materials necessary to implement the hands-on lab activities to the participant educators. Teachers are now part of an ongoing learning community that regularly meets with their cohort and master instructor throughout the school year for continued support.

“Hands-on teaching takes practice, courage, preparation, and resources,” said RTTI Director Kristin Boscan. “Our goal is to eliminate obstacles to life science education and careers through training, support and equipment supplementation.”

Georgia BioEd Rural Teacher Training Initiative (RTTI) participants

The symposium included an “industry fair” to inform educators about the life science industry in their own backyard, better equipping them to inspire and direct students to successful and frequently lucrative life science careers. The industry fair will certainly foster relationships that lead to industry tours, school field trips and internships.

“You can’t strive towards what you don’t know about,” said Ayesha Okaiwele, a science teacher in the Houston County School System. “When students hear the phrase ‘agriculture careers’ they often think that means farming and becoming a farmer. When, in fact, there’s the technical side of agriculture which involves laboratory work.”

Georgia BioEd Rural Teacher Training Initiative (RTTI) participants

Georgia’s life science industry experienced a 14.9 percent growth in employment from 2007 to 2017, according to the 2019 Georgia Life Sciences State of the Industry Report. Maria Saporta further wrote for the Atlanta Business Chronicle, “The report identified 1,960 unique life science establishments that contributed 68,300 jobs and $10 billion to Georgia’s gross domestic product. When including the multiplier effects, the industry supports a total of about 194,000 jobs, and it contributes $21.8 billion to Georgia’s GDP.”

However, researchers at Georgia Tech found just 4.6 percent of Georgia high schools offer the full biotechnology pathway. They also found that less than one half of one percent of Georgia’s 12th grade students completed the final course in that pathway. This demonstrates a clear need for additional education and workforce development.

In addition to financial and in-kind funding from life science companies in Georgia, the state allocated $323,000 in 2019 for the inaugural program including lab implementation and ongoing support. Georgia BioEd is working to secure state funding during the 2020 legislative session to ensure the program continues on an annual basis.

Georgia BioEd Rural Teacher Training Initiative (RTTI) participants

“The best thing we can do here in Georgia is to create an ecosystem that continues to allow for a growing economy, a talented workforce and significant potential in front of it,” Lt. Governor David Duncan told Georgia Bio last year.

Interested educators can subscribe to the RTTI outreach list and monthly newsletter by emailing mheaphy@gabio.org

“We are grateful to our board members, industry supporters and state leaders for providing the support needed to ensure Georgia can generate the future workforce for the state’s $21 billion life science industry,” Boscan said.

Georgia BioEd Rural Teacher Training Initiative (RTTI) participants

Georgia Bio expresses our gratitude to the following state legislative leadership for helping to make this valuable initiative real to the benefit of all Georgians: Governor Brian Kemp, Lt. Governor Geoff Duncan, House Appropriations Chairman Terry England, Senate Appropriations Chairman Jack Hill, House Appropriations Education Subcommittee Chairman Robert Dickey, Senate Appropriations Education Subcommittee Chairman Ellis Black, Senate Agriculture Chairman John Wilkinson, and House Ethics Chairman Randy Nix.

***

Georgia Bio and the Georgia BioEd Institute would like to thank supporters of the inaugural RTTI Program.

Champions

  • Accenture
  • Annette and Denny Ivey
  • Avantor/VWR  
  • BioRad
  • Dendreon
  • Lab Design and Supply
  • MedShare
  • Sorbtech
  • Takeda
  • The Pipette Solution
  • ThermoFisher
  • Waypoint Analytical

Key Supporters

  • Beate Lloyd
  • Boehringer-Ingelheim
  • Cell Manufacturing Technologies
  • Emory University
  • Georgia Association of Water Professionals
  • Georgia Department of Agriculture
  • Georgia Department of Education
  • Georgia Poultry Laboratory Network
  • Georgia Power
  • Georgia State University
  • Georgia Tech
  • Georgia Youth Science and Technology Centers
  • Gerresheimer
  • Global Center for Medical Innovation
  • GSU BioBus
  • Kennesaw State University
  • Morehouse School of Medicine
  • Quest Diagnostics
  • Recro Gainesville
  • TCSG – Athens Tech
  • UGA – Griffin and Young Scholars’ Program
  • UGA’s Bioexpression and Fermentation Facility
Inaugural Rural Teacher Training Initiative (RTTI) participants 2020
June 17, 2026
As part of the Georgia Life Sciences Summit (August 25–26), applications are now open for the Startup Showcase , sponsored by Johnson & Johnson , highlighting early-stage innovation across MedTech and Therapeutics . The Showcase will feature some of Georgia’s most innovative life science startups, giving emerging companies the opportunity to present groundbreaking technologies, products, and solutions to a distinguished audience of industry leaders, investors, researchers, and partners. Selected startups will present during the August 26 luncheon program and participate in a live investor Q&A session with John Gutierrez (Ascenta Capital), Emma Heckenberg, Ph.D. (Solas BioVentures), Patrick Jordan (NovaQuest Capital Management), and Emily Dinu (Numinous Capital) Members of the Johnson & Johnson external innovation team will also be onsite for the program and select companies will be scheduled for a 1:1 meeting to discuss strategic alignment and potential collaboration opportunities. If you or companies in your network are building in MedTech or Therapeutics, this is a strong opportunity to gain visibility, receive feedback on commercialization and growth strategy, and connect with key stakeholders. All applicants receive a complimentary Summit registration, and one selected company will also be invited to participate in the NewYorkBIO / New York Stock Exchange Life Sciences Showcase on December 10. If this is relevant to your work, it would be a strong opportunity to consider applying. If not, it may be worth sharing with companies in your network who are building in this space.
June 15, 2026
Workforce & Education Impact: Building Georgia's Future  Life Sciences Workforce - One Teacher at a Time June 16, 2026 - As Georgia Life Sciences concludes the 2025-2026 cycle of the Biotech Teacher Training Initiative (BTTI), the results reinforce the critical role educators play in building the state's future life sciences workforce. Since July of 2025, BTTI engaged 98 educators representing 40 schools across 23 school systems, reaching an estimated 5,375 students through hands-on biotechnology instruction, career-connected learning, and industry-relevant classroom experiences. The Georgia Life Sciences Equipment Depot further expanded the program's impact by supporting 238 teachers with access to laboratory equipment and materials that make authentic life sciences learning possible. Georgia Life Sciences is also pleased to report that funding for BTTI was maintained in the Georgia House version of the FY 2027 budget approved earlier this year. The upcoming 2026-2027 program cycle will mark an important evolution for BTTI. Building on feedback from industry partners and workforce trends across the life sciences sector, Georgia Life Sciences will expand the program's scope to better reflect the skills and competencies employers increasingly need. In addition to foundational biotechnology concepts, future programming will be organized around key industry domains, including Quality Assurance and Quality Control (QA/QC), Research & Development (R&D), MedTech, Artificial Intelligence, Automation, and Advanced Manufacturing. This expanded approach will provide educators with greater insight into the breadth of career opportunities available across Georgia's life sciences ecosystem while helping students develop awareness of the technologies and disciplines shaping the industry's future. The impact extends far beyond individual workshops, creating lasting connections between Georgia classrooms and the state's growing life sciences ecosystem while helping build the talent pipeline that will power Georgia's future innovation economy. "Before BTTI, I was hesitant to do biotech labs because they seemed too complex and expensive," shared Josephine Jeganathan of Stockbridge High School. "The program showed me how simplified it can be and provided the equipment and materials needed to successfully implement the Central Dogma Lab with all my classes." Teachers are also seeing increased student engagement through hands-on learning experiences. Tonie Curry of North Clayton High School used a chromatography lab to connect environmental science concepts to water pollution and sustainability. "Students were highly interested in seeing how substances separated and made strong connections to water pollution and environmental sustainability," Curry noted. "The hands-on nature of the lab encouraged curiosity and deeper understanding." For many educators, one of the most valuable aspects of the program is the connection between classroom learning and real-world careers. As Marshai Waiters of Marietta Middle School reflected: "Exposure is key. There are so many avenues to work in STEM, and they are all accessible with opportunity and knowledge. The insights gained from industry speakers will inform my teaching and create new opportunities for student exposure." When teachers are trained, equipped, and connected to industry, students gain more than a science lesson—they gain a window into Georgia's life sciences future.
June 10, 2026
In recent comments to the Department of Justice (DOJ) and Federal Trade Commission (FTC), PULSE highlighted critical reforms to ensure that U.S. competition policies support – and do not impede – the pro-competitive mergers and acquisitions (M&A) and other collaborations that drive American life sciences innovation. PULSE submitted comments in response to two joint DOJ/FTC Requests related to Guidance on Collaborations Among Competitors and Improvements to the Premerger Notification and Report Form (HSR Form). Read below for key takeaways from PULSE’s comment letters: 1. Life Sciences Innovation Depends on Collaboration “At its core, life sciences innovation is overwhelmingly collaborative. The cutting-edge medicines and cures developed by America’s life sciences industry are rarely the result of just one sole actor. Instead, they more often emerge from a calibrated sequence of partnerships… that collectively usher a biomedical breakthrough from early-stage discovery to FDA approval and delivery to patients.” – PULSE, Comments on Guidance on Collaborations Among Competitors 2. Policies that Ignore the Fundamental Role of Life Sciences M&A Risk Chilling Innovation for Patients “Against the significant challenges and pressures inherent to life sciences innovation, such policies that needlessly delay pro-competitive transactions have significant ripple effects: eroded investment incentives, disruptions in the path to launch and, ultimately, slowed or stalled development of new treatments and cures for patients.” – PULSE, Comments on Improvements to the HSR Form 3. Clear, Predictable Standards Can Support Competition and Innovation in America’s Life Sciences Ecosystem “Preserving clear and workable pathways for collaboration is therefore essential to sustain the broader ecosystem that delivers innovation and sustains America’s status as the world leader in life sciences innovation.” – PULSE, Comments on Guidance on Collaborations Among Competitors Leading business and industry organizations echoed and reinforced these priorities. Their comments highlight the unique market dynamics of life sciences innovation and the importance of collaboration and M&A – particularly with respect to early-stage R&D. “Because drug development typically takes over a decade, and the vast majority of drugs in development never make it to market, the antitrust risks associated with R&D collaborations in this space may be less than with other R&D collaborations.” – ABA Antitrust Law Section, Comments on Guidance on Collaborations Among Competitors “In the biopharmaceutical sector, for instance, R&D ventures in the pre-clinical or Phase I stages should be presumed lawful. At these early stages, about 90% of drugs never make it to market, so these collaborations are far too distant from commercialization to pose a meaningful threat to competition.” – U.S. Chamber of Commerce, Comments on Guidance for Collaborations Among Competitors “Healthy M&A activity also aids company formation and capital raising earlier in a business’s life cycle, as entrepreneurs and early-stage investors often depend on M&A for an exit opportunity. Conversely, discouraging business combinations by imposing burdensome one-size-fits-all standards on all transactions, like those imposed by the 2024 amendments, would disincentivize early-stage innovation and slow down economic growth.” – National Association of Manufacturers, Comments on Improvements to the HSR Form The bottom line: A balanced approach to antitrust enforcement policy should support life sciences M&A and other collaborations, ensuring new medicines continue to reach patients, while preserving a diverse and collaborative ecosystem. PULSE urges the agencies to adopt clear, workable and predictable standards that companies can apply with confidence. That includes preserving enforcement safety zones for low-risk, pro-competitive collaborations, as well as ensuring the HSR Form facilitates a timely, focused and fit-for-purpose screening process for life sciences M&A deals. Click below to read PULSE’s full comments: PULSE Comments on Guidelines on Collaborations Among Competitors PULSE Comments on Improvements to the HSR Form Source: PULSE Urges FTC, DOJ to Support Pro-Competitive Life Sciences Collaborations and M&A - Partnership for the U.S. Life Science Ecosystem (PULSE)
MORE POSTS